117 related articles for article (PubMed ID: 23429588)
21. Bioequivalence study of two tablet formulations of sildenafil.
Spínola AC; Almeida S; Filipe A; Tanguay M; Yritia M
Arzneimittelforschung; 2008; 58(3):122-5. PubMed ID: 18488808
[TBL] [Abstract][Full Text] [Related]
22. [Sildenafil as a substitute for subcutaneous prostacyclin in pulmonary hypertension].
Cea-Calvo L; Escribano Subías P; Tello de Menesses R; Gómez Sánchez MA; Delgado Jiménez JF; Sáenz de la Calzada C
Arch Bronconeumol; 2003 Oct; 39(10):476-7. PubMed ID: 14533998
[TBL] [Abstract][Full Text] [Related]
23. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
[TBL] [Abstract][Full Text] [Related]
24. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
25. Oral treprostinil for the treatment of pulmonary arterial hypertension.
de Lartigue J
Drugs Today (Barc); 2014 Aug; 50(8):557-65. PubMed ID: 25187906
[TBL] [Abstract][Full Text] [Related]
26. Transitioning Parenteral or Inhaled Treprostinil to Oral Treprostinil Diolamine: Case Series and Review of the Literature.
Smith ZR; Kelly B; Awdish RL; Hegab S
J Pharm Pract; 2019 Oct; 32(5):599-604. PubMed ID: 29558853
[TBL] [Abstract][Full Text] [Related]
27. A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration.
Kumar P; Thudium E; Laliberte K; Zaccardelli D; Nelsen A
Clin Pharmacokinet; 2016 Dec; 55(12):1495-1505. PubMed ID: 27286723
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
[TBL] [Abstract][Full Text] [Related]
29. The effects of sitaxentan on sildenafil pharmacokinetics and pharmacodynamics in healthy subjects.
Stavros F; Kramer WG; Wilkins MR
Br J Clin Pharmacol; 2010 Jan; 69(1):23-6. PubMed ID: 20078609
[TBL] [Abstract][Full Text] [Related]
30. Combining treprostinil and sildenafil in the treatment of pulmonary hypertension.
Chua R; Keogh A
Intern Med J; 2005 Nov; 35(11):684-5. PubMed ID: 16248867
[No Abstract] [Full Text] [Related]
31. Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
LeVarge BL; Channick RN
Expert Rev Respir Med; 2012 Jun; 6(3):255-65. PubMed ID: 22788940
[TBL] [Abstract][Full Text] [Related]
32. Sildenafil for pulmonary hypertension.
Lee AJ; Chiao TB; Tsang MP
Ann Pharmacother; 2005 May; 39(5):869-84. PubMed ID: 15827074
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic evaluation of treprostinil (oral) for the treatment of pulmonary arterial hypertension.
Hellawell JL; Bhattacharya S; Farber HW
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1445-53. PubMed ID: 25204984
[TBL] [Abstract][Full Text] [Related]
34. Comparison of fasting bioavailability among 100-mg commercial, 100-mg generic, and 50-mg chewable generic sildenafil tablets in healthy male Mexican volunteers: a single-dose, 3-period, crossover study.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; García-González A; Ramírez-San Juan E
Clin Ther; 2012 Mar; 34(3):689-98. PubMed ID: 22386826
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of sildenafil in a patient treated with human immunodeficiency virus protease inhibitors.
Aschmann YZ; Kummer O; Linka A; Wenk M; Azzola A; Bodmer M; Krähenbühl S; Haschke M
Ther Drug Monit; 2008 Feb; 30(1):130-4. PubMed ID: 18223477
[TBL] [Abstract][Full Text] [Related]
36. Are nitrates safe in patients who use sildenafil? Maybe.
Werns SW
Crit Care Med; 2007 Aug; 35(8):1988-90. PubMed ID: 17667250
[No Abstract] [Full Text] [Related]
37. Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects.
Wrishko RE; Dingemanse J; Yu A; Darstein C; Phillips DL; Mitchell MI
J Clin Pharmacol; 2008 May; 48(5):610-8. PubMed ID: 18305126
[TBL] [Abstract][Full Text] [Related]
38. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats.
Itoh T; Nagaya N; Fujii T; Iwase T; Nakanishi N; Hamada K; Kangawa K; Kimura H
Am J Respir Crit Care Med; 2004 Jan; 169(1):34-8. PubMed ID: 14525801
[TBL] [Abstract][Full Text] [Related]
39. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
Gessler T; Seeger W; Schmehl T
Ther Adv Respir Dis; 2011 Jun; 5(3):195-206. PubMed ID: 21300738
[TBL] [Abstract][Full Text] [Related]
40. Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension.
Goland S; Tsai F; Habib M; Janmohamed M; Goodwin TM; Elkayam U
Cardiology; 2010; 115(3):205-8. PubMed ID: 20173324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
